Light‐Tunable Generation of Singlet Oxygen and Nitric Oxide with a Bichromophoric Molecular Hybrid: a Bimodal Approach to Killing Cancer Cells
暂无分享,去创建一个
Loretta Lazzarato | Roberta Fruttero | Alberto Gasco | Ilse Manet | V. Cardile | L. Lazzarato | R. Fruttero | A. Gasco | Aurore Fraix | S. Sortino | I. Manet | Salvatore Sortino | A. Graziano | Venera Cardile | Aurore Fraix | Marco Blangetti | Stefano Guglielmo | Nino Marino | Adriana C E Graziano | Stefano Guglielmo | Nino Marino | Marco Blangetti
[1] Patrycja Nowak-Sliwinska,et al. In vitro and in vivo photocytotoxicity of boron dipyrromethene derivatives for photodynamic therapy. , 2010, Journal of medicinal chemistry.
[2] V. Cardile,et al. Raf kinase inhibitor protein (RKIP) and phospho-RKIP expression in melanomas. , 2013, Acta histochemica.
[3] D. Nowis,et al. Light and Light Sources for Pdt Direct Tumor Damage Mechanisms of Photodynamic Therapy , 2005 .
[4] Shaomin Ji,et al. Organic triplet sensitizer library derived from a single chromophore (BODIPY) with long-lived triplet excited state for triplet-triplet annihilation based upconversion. , 2011, The Journal of organic chemistry.
[5] V. Cardile,et al. An engineered nanoplatform for bimodal anticancer phototherapy with dual-color fluorescence detection of sensitizers. , 2013, Chemical communications.
[6] P. Mascharak,et al. Photoactive ruthenium nitrosyls as NO donors: how to sensitize them toward visible light. , 2011, Accounts of chemical research.
[7] Kevin Burgess,et al. BODIPY dyes and their derivatives: syntheses and spectroscopic properties. , 2007, Chemical reviews.
[8] R. Parenti,et al. Wilms’ Tumor Gene 1 (WT1) Silencing Inhibits Proliferation of Malignant Peripheral Nerve Sheath Tumor sNF96.2 Cell Line , 2014, PloS one.
[9] Shiguo Sun,et al. Carboxyl BODIPY dyes from bicarboxylic anhydrides: one-pot preparation, spectral properties, photostability, and biolabeling. , 2009, The Journal of organic chemistry.
[10] S. Sortino. Light-controlled nitric oxide delivering molecular assemblies. , 2010, Chemical Society reviews.
[11] S. Monti,et al. Supramolecular photochemistry of drugs in biomolecular environments. , 2014, Chemical Society reviews.
[12] B. Wilson,et al. The physics, biophysics and technology of photodynamic therapy , 2008, Physics in medicine and biology.
[13] Michael R Hamblin,et al. Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death. , 2005, Photodiagnosis and photodynamic therapy.
[14] S. Wimalawansa. Nitric oxide: new evidence for novel therapeutic indications , 2008 .
[15] S. Huerta,et al. Nitric oxide donors: novel cancer therapeutics (review). , 1992 .
[16] L. Arnaut,et al. Photodynamic therapy (PDT) of cancer: from local to systemic treatment , 2015, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[17] J. Lancaster,et al. Nitric oxide: a new paradigm for second messengers. , 1995, Journal of medicinal chemistry.
[18] A. W. Carpenter,et al. Nitric oxide release: part II. Therapeutic applications. , 2012, Chemical Society reviews.
[19] M. Biel. Photodynamic therapy of bacterial and fungal biofilm infections. , 2010, Methods in molecular biology.
[20] David Kessel,et al. Photodynamic therapy of cancer: An update , 2011, CA: a cancer journal for clinicians.
[21] B. Krammer,et al. Vascular effects of photodynamic therapy. , 2001, Anticancer research.
[22] D. Wink,et al. The biphasic nature of nitric oxide responses in tumor biology. , 2006, Antioxidants & redox signaling.
[23] Michael R Hamblin,et al. Photodynamic therapy: a new antimicrobial approach to infectious disease? , 2004, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[24] Michael R Hamblin,et al. Mechanisms in photodynamic therapy: Part three-Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction. , 2005, Photodiagnosis and photodynamic therapy.
[25] S. Sortino,et al. Two-photon fluorescence imaging and bimodal phototherapy of epidermal cancer cells with biocompatible self-assembled polymer nanoparticles. , 2014, Biomacromolecules.
[26] Youngjae You,et al. Boron dipyrromethene (BODIPY)-based photosensitizers for photodynamic therapy , 2012 .
[27] Paul Baas,et al. Photodynamic therapy in oncology. , 2006, The oncologist.
[28] Harold S. Freeman,et al. Dye Sensitizers for Photodynamic Therapy , 2013, Materials.
[29] P. Ford. Photochemical delivery of nitric oxide. , 2013, Nitric oxide : biology and chemistry.
[30] R Lecomte,et al. Vascular-targeted photodynamic therapy with BF2-chelated Tetraaryl-Azadipyrromethene agents: a multi-modality molecular imaging approach to therapeutic assessment , 2009, British Journal of Cancer.
[31] John F. Callan,et al. Carbon quantum dot-NO photoreleaser nanohybrids for two-photon phototherapy of hypoxic tumors. , 2015, Chemical communications.
[32] C. Ratanatawanate,et al. S-nitrosocysteine-decorated PbS QDs/TiO2 nanotubes for enhanced production of singlet oxygen. , 2011, Journal of the American Chemical Society.
[33] A. Noronha-Dutra,et al. Reaction of nitric oxide with hydrogen peroxide to produce potentially cytotoxic singlet oxygen as a model for nitric oxide‐mediated killing , 1993, FEBS letters.
[34] Takayoshi Suzuki,et al. Visible light-induced nitric oxide release from a novel nitrobenzene derivative cross-conjugated with a coumarin fluorophore. , 2014, Bioorganic & medicinal chemistry letters.
[35] Takayoshi Suzuki,et al. Photoinduced nitric oxide release from nitrobenzene derivatives. , 2005, Journal of the American Chemical Society.
[36] R. E. Kellogg,et al. Radiationless Intermolecular Energy Transfer. III. Determination of Phosphorescence Efficiencies , 1964 .
[37] Frank Verhaegen,et al. Spectroscopic characterization of a novel electronic brachytherapy system , 2008, Physics in medicine and biology.
[38] Ming Xian,et al. Nitric oxide donors: chemical activities and biological applications. , 2002, Chemical reviews.
[39] P. Ford. Polychromophoric metal complexes for generating the bioregulatory agent nitric oxide by single- and two-photon excitation. , 2008, Accounts of chemical research.
[40] S. Sortino,et al. Amplified nitric oxide photorelease in DNA proximity. , 2008, Chemical communications.
[41] K. Ghiggino,et al. Singlet oxygen quantum yields of potential porphyrin-based photosensitisers for photodynamic therapy , 2007, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[42] V. Ponomarev,et al. Mechanism of cell death mediated by a BF2‐chelated tetraaryl‐azadipyrromethene photodynamic therapeutic: Dissection of the apoptotic pathway in vitro and in vivo , 2012, International journal of cancer.
[43] L. Arnaut,et al. Modulation of Biodistribution, Pharmacokinetics, and Photosensitivity with the Delivery Vehicle of a Bacteriochlorin Photosensitizer for Photodynamic Therapy , 2014, ChemMedChem.
[44] S. Petralia,et al. Photodelivery of nitric oxide from water-soluble platinum nanoparticles. , 2007, Journal of the American Chemical Society.
[45] V. Cardile,et al. A multi-photoresponsive molecular-hybrid for dual-modal photoinactivation of cancer cells , 2014 .
[46] T. Parisi,et al. A cyclodextrin-based nanoassembly with bimodal photodynamic action. , 2012, Chemistry.
[47] K. Burgess,et al. BODIPY dyes in photodynamic therapy. , 2013, Chemical Society reviews.
[48] I. Perillo,et al. Selective Monoformylation Of 1,3-Diaminopropane Derivatives , 1999 .
[49] Y. Urano,et al. Highly efficient and photostable photosensitizer based on BODIPY chromophore. , 2005, Journal of the American Chemical Society.
[50] S. Gibson,et al. Current clinical and preclinical photosensitizers for use in photodynamic therapy. , 2004, Journal of medicinal chemistry.
[51] P. Wang,et al. Recent developments in anticancer nitric oxide donors , 2004 .
[52] C. Brett,et al. Photodynamic therapy efficacy enhanced by dynamics: the role of charge transfer and photostability in the selection of photosensitizers. , 2014, Chemistry.
[53] K. Yeung,et al. Novel therapeutic applications of nitric oxide donors in cancer: roles in chemo- and immunosensitization to apoptosis and inhibition of metastases. , 2008, Nitric oxide : biology and chemistry.
[54] Jason R. Hickok,et al. Nitric oxide and cancer therapy: the emperor has NO clothes. , 2010, Current pharmaceutical design.
[55] Stanley B. Brown,et al. The present and future role of photodynamic therapy in cancer treatment. , 2004, The Lancet. Oncology.
[56] T. Maisch. A new strategy to destroy antibiotic resistant microorganisms: antimicrobial photodynamic treatment. , 2009, Mini reviews in medicinal chemistry.
[57] Michael R Hamblin,et al. Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization. , 2004, Photodiagnosis and photodynamic therapy.
[58] J. Lehmann. Nitric oxide donors - current trends in therapeutic applications , 2000 .
[59] N. Hogg,et al. Cancer cell metabolism and the modulating effects of nitric oxide. , 2015, Free radical biology & medicine.
[60] R. Jain,et al. The role of nitric oxide in tumour progression , 2006, Nature Reviews Cancer.